Hansepran Capsule (Clofazimine 100mg) | Used in Leprosy Treatment and Skin Infection Management
Hansepran Capsule (Clofazimine 100mg) is an anti leprosy medicine used in the treatment of Hansen disease and related skin infections. It helps control bacterial growth, reduces inflammation, and supports long term management of multibacillary leprosy. It is commonly used as part of combination therapy for effective infection control and symptom improvement.
Product Overview
Hansepran Capsule is a specialized antimycobacterial agent formulated for the treatment and long-term clinical management of leprosy. Containing the active therapeutic compound Clofazimine at a strength of 100mg, this tissue-binding medication is an essential component of the World Health Organization (WHO) recommended multi-drug therapy (MDT) regimen. It works by halting the growth of the causative bacteria while simultaneously exerting a powerful anti-inflammatory effect. Hansepran is primarily utilized to treat multi-bacillary leprosy and manage complex inflammatory complications, helping to prevent disease transmission, arrest tissue damage, and support full bacteriological clearance.
Product Composition
- Active Pharmaceutical Ingredient: Clofazimine (100mg per oral capsule)
- Dosage Form: Soft gelatin oral capsules designed to maximize the bioavailability of the highly lipophilic active compound
- Core Excipients: Formulated with a suspension of micronized clofazimine in an oil-based vehicle (such as soybean oil or beeswax) to facilitate optimal gastrointestinal absorption
Product Specification
| Product Parameter | Details |
| Brand Name | Hansepran Capsule |
| Active Ingredient | Clofazimine |
| Therapeutic Class | Antimycobacterials / Anti-leprosy Agents |
| Available Strength | 100mg |
| Primary Indications | Lepromatous leprosy, multi-bacillary leprosy, and Erythema Nodosum Leprosum (ENL) reactions |
Mechanism of Action
- DNA Binding and Replication Inhibition: Clofazimine binds preferentially to the mycobacterial DNA of Mycobacterium leprae, disrupting the replication process and inhibiting bacterial growth.
- Generation of Retarding Free Radicals: It undergoes intracellular redox cycling to generate toxic superoxide oxygen radicals, which directly damage the bacterial cell membrane structures.
- Anti-Inflammatory Suppression: Beyond its bactericidal actions, clofazimine inhibits T-lymphocyte activation and downregulates pro-inflammatory mediators. This dual mechanism effectively suppresses the severe immune-mediated systemic inflammatory reactions associated with leprosy flare-ups.
Key Benefits
- Serves as a fundamental core component of multi-drug regimens to prevent the development of drug-resistant strains of Mycobacterium leprae.
- Provides powerful, dual-action clinical efficacy by killing the causative bacteria while simultaneously controlling painful systemic inflammatory flares.
- Significantly reduces the ultimate requirement for long-term concomitant corticosteroid therapies during acute inflammatory episodes.
- Features a highly lipophilic property that allows the drug to deposit extensively into fatty tissues and reticuloendothelial cells, ensuring sustained, continuous therapeutic coverage.
Precautions
Important Precautions for Hansepran Capsule (Clofazimine 100mg)
Hansepran Capsule is used in leprosy treatment and inflammation management. Proper monitoring is important during long-term use.
| Precaution Area | Details |
|---|---|
| Skin Discoloration | May cause skin darkening or discoloration. |
| Digestive Health | Use carefully in stomach disorders. |
| Liver Function | Monitor liver health if needed. |
| Allergic Reaction | Avoid if allergic to Clofazimine. |
| Pregnancy | Use only if clearly needed. |
| Long Term Use | Regular monitoring may be required. |
| Mental Health | Report mood or behavior changes. |
Important Safety Advice
- Take regularly as directed
- Do not stop treatment suddenly
- Inform about any stomach pain or bowel changes
- Report unusual skin discoloration if severe
- Maintain follow-up during long-term therapy
When to Avoid Hansepran Capsule
- Known allergy to Clofazimine
- Severe digestive disorders without monitoring
- Serious liver problems requiring caution
Monitoring Requirements
- Skin and body color changes
- Digestive health assessment
- Liver function monitoring if required
- Regular treatment response evaluation
Usage
This specialized antimycobacterial medication requires absolute adherence to long-term therapy schedules and must always be used as part of a combination regimen to prevent drug resistance. Because the active ingredient is highly fat-soluble, it must be taken during meals to ensure proper therapeutic levels are absorbed into the body. Healthcare providers must perform continuous clinical monitoring, including periodic electrocardiogram (ECG) heart rhythm checks and regular evaluations for severe gastrointestinal toxicities.
| Parameter | Clinical Guidelines |
| Standard Dosage | Typically ranges from 50mg to 100mg once daily combined with other anti-leprosy medicines, or up to 300mg daily for acute inflammatory flare-ups under strict medical supervision. |
| Administration Route | For oral use only. Swallow the capsules whole with a full glass of water. Do not open, crush, or chew the soft gelatin shell. |
| Dietary Requirement | Always take the capsule directly with food or a glass of milk. This maximizing gastrointestinal absorption and helps minimize severe stomach irritation. |
| Therapy Compliance | Treatment courses are prolonged, frequently lasting from 12 months to 2 years. Patients must complete the full prescribed duration even if symptoms improve early. |
Uses
Multi-Bacillary Leprosy Treatment: Indicated as a mandatory core component of the World Health Organization (WHO) multi-drug therapy (MDT) regimen to eliminate multi-bacillary Mycobacterium leprae infections.
Management of Lepra Reactions (Type 2): Prescribed to treat and suppress Erythema Nodosum Leprosum (ENL), a severe, painful immune-mediated systemic inflammatory reaction common in leprosy patients.
Prevention of Bacterial Resistance: Utilized in combination with other antibiotics (such as rifampicin and dapsone) to prevent the causative bacteria from mutating and developing drug resistance.
Treatment of Resistant Mycobacterial Infections: Employed as an alternative or off-label therapeutic option for managing non-tuberculous mycobacterial diseases, including Mycobacterium avium complex (MAC) in immunocompromised individuals.
Side Effects
Possible Side Effects of Hansepran Capsule (Clofazimine 100mg)
Hansepran Capsule is generally used in long-term leprosy treatment. Some side effects may occur, especially with prolonged use.
| Side Effect Type | Details |
|---|---|
| Common Effects | Skin discoloration, dryness. |
| Digestive System | Stomach pain, diarrhea, nausea. |
| Skin Effects | Redness, itching, dryness. |
| Eye Effects | Eye irritation or dryness. |
| Liver Effects | Rare changes in liver function. |
| General Effects | Fatigue or weakness. |
Common Side Effects
- Skin darkening or discoloration
- Dry skin
- Mild stomach discomfort
- Diarrhea or nausea
Less Common But Important Effects
- Severe abdominal pain
- Persistent skin irritation
- Eye discomfort or dryness
- Signs of liver problems
When to Be Careful
- Severe or persistent stomach pain
- Yellowing of skin or eyes
- Severe skin reactions
- Unusual fatigue or weakness
General Note
- Skin discoloration is usually reversible after stopping treatment
- Long-term monitoring helps reduce risks
- Report any severe or persistent symptoms promptly
FAQs
Q: What is Hansepran Capsule used for?
A: This specialized antimycobacterial medication is a core component of the multi-drug therapy (MDT) regimen used to treat multi-bacillary leprosy (Mycobacterium leprae infections). It is also highly effective in treating Erythema Nodosum Leprosum, a painful, inflammatory skin complication of leprosy.
Q: Does Clofazimine cause changes in skin color?
A: Yes, this is a very common and expected side effect. The drug is a highly lipophilic dye that builds up in fatty tissues, causing a reversible skin discoloration ranging from pink to reddish-brown or nearly black. It can also discolor sweat, tears, and urine. The skin color returns to normal months after stopping treatment.
Q: How should Hansepran Capsules be taken?
A: It must be administered strictly via oral use and should always be taken with food or a glass of milk. Taking it with a meal significantly increases gastrointestinal absorption and helps reduce stomach irritation.
Q: What are the gastrointestinal risks associated with long-term use?
A: Because the active drug deposits into the tissues of the small intestine, long-term high-dose therapy can cause crystals to form in the intestinal walls. This can lead to severe abdominal pain, nausea, diarrhea, and in rare cases, intestinal obstruction.
Q: Can this medication cause dry skin and eyes?
A: Yes, many patients experience severe dryness, scaling, and itchiness of the skin (ichthyosis), as well as dry eyes or irritation. Using moisturizing lotions and lubricating eye drops can help manage these symptoms during therapy.
Q: Does Hansepran affect the heart's electrical rhythm?
A: Yes, clofazimine can cause QT prolongation, which is an alteration in the electrical rhythm of the heart. Patients with pre-existing heart conditions should have their heart function tracked via regular electrocardiograms (ECGs) during treatment.
Interactions
Drug Interactions of Hansepran Capsule (Clofazimine 100mg)
Hansepran Capsule may interact with medicines that affect the immune system, digestion, or liver function. Inform about all ongoing medicines before use.
| Medicine or Product Type | Interaction Details |
|---|---|
| Other Anti leprosy Drugs | Often used together; monitor response. |
| Antibiotics | May alter treatment effectiveness. |
| Anti inflammatory Drugs | Can affect symptom control. |
| Liver Affecting Medicines | May increase liver strain. |
| Antacids | May reduce absorption slightly. |
| Immune Modulators | Can affect immune response balance. |
Important Interaction Advice
- Use combination therapy only under supervision
- Maintain consistent dosing schedule
- Inform about all antibiotics or skin medicines in use
- Monitor treatment response regularly
General Guidance
- Regular checkups are important in long-term therapy
- Report stomach discomfort or unusual symptoms
- Do not stop or combine medicines without guidance
- Track skin and symptom changes during treatment
Additional Note
- Always provide full medical history before starting Hansepran Capsule to avoid interaction risks
| Manufacturer | : | Abbott, India |
| Trade Name | : | Lamprene |
| Generic Search | : | Clofazimine |
| Strength | : | 100mg |
Latest Products
